431 related articles for article (PubMed ID: 23859979)
1. Does comorbid alcohol and substance abuse affect electroconvulsive therapy outcome in the treatment of mood disorders?
Moss L; Vaidya N
J ECT; 2014 Mar; 30(1):22-5. PubMed ID: 23859979
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV; Groft A
J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
[TBL] [Abstract][Full Text] [Related]
5. Substance use disorders increase the odds of subsequent mood disorders.
Kenneson A; Funderburk JS; Maisto SA
Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
[TBL] [Abstract][Full Text] [Related]
6. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy for mood disorders in pregnancy.
Bulut M; Bez Y; Kaya MC; Copoglu US; Bulbul F; Savas HA
J ECT; 2013 Jun; 29(2):e19-20. PubMed ID: 23519218
[TBL] [Abstract][Full Text] [Related]
8. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
[TBL] [Abstract][Full Text] [Related]
9. A retrospective comparison of the effects of propofol and etomidate on stimulus variables and efficacy of electroconvulsive therapy in depressed inpatients.
Graveland PE; Wierdsma AI; van den Broek WW; Birkenhäger TK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():230-5. PubMed ID: 23774194
[TBL] [Abstract][Full Text] [Related]
10. Potential benefits of quetiapine in the treatment of substance dependence disorders.
Sattar SP; Bhatia SC; Petty F
J Psychiatry Neurosci; 2004 Nov; 29(6):452-7. PubMed ID: 15644986
[TBL] [Abstract][Full Text] [Related]
11. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
12. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
13. [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity].
van Waarde JA; Stek ML
Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1693-7. PubMed ID: 11561488
[TBL] [Abstract][Full Text] [Related]
14. ECT for the treatment of mood disorders in cancer patients.
Beale MD; Kellner CH; Parsons PJ
Convuls Ther; 1997 Dec; 13(4):222-6. PubMed ID: 9437566
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive therapy as an alternative treatment for obese patients with mood disorders.
Moss LE; Vaidya NA
J ECT; 2006 Sep; 22(3):223-5. PubMed ID: 16957541
[TBL] [Abstract][Full Text] [Related]
16. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
[TBL] [Abstract][Full Text] [Related]
18. Are clinical impressions of adolescent substance use accurate?
Wilson CR; Sherritt L; Gates E; Knight JR
Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
[TBL] [Abstract][Full Text] [Related]
19. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders.
Kurt E; Guler O; Serteser M; Cansel N; Ozbulut O; Altinbaş K; Alataş G; Savaş H; Gecici O
Neurosci Lett; 2007 Oct; 426(1):49-53. PubMed ID: 17884293
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD).
Ohlmeier MD; Peters K; Kordon A; Seifert J; Wildt BT; Wiese B; Ziegenbein M; Emrich HM; Schneider U
Alcohol Alcohol; 2007; 42(6):539-43. PubMed ID: 17766314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
